Transcriptional mechanisms of acute lung injury

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 281, Issue 5 25-5, 2001, Pages

  Fan, Jie ^a   Ye, Richard D ^a   Malik, Asrar B ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Cytokine; Nuclear factor B; Pulmonary inflammation; Transcription factor

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 13; TOLL LIKE RECEPTOR;

GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNE SYSTEM; INFLAMMATION; LUNG INJURY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0035199686     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.281.5.l1037     Document Type: Review

References (161)

1. HMG-1 as a mediator of acute lung inflammation
2. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury
3. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway
4. Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm
5. Tissue factor expression in vital organs during murine traumatic shock: Role of transcription factors AP-1 and NF-kappaB
6. Acute respiratory distress in adults
7. Pro-inflammatory signaling: Last pieces in the NF-kappaB puzzle?
8. NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules
9. NF-kappa B: Ten years after
10. The NF-kappa B and I kappa B proteins: New discoveries and insights
11. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
12. Depletion of alveolar macrophages by liposome-encapsulated dichloromethylene diphosphonate
13. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial co-ordination
14. Mouse bcl-3: cDNA structure, mapping and stage-dependent expression in B lymphocytes
15. Flexing DNA: HMG-box proteins and their partners
16. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation
17. The role of nuclear factor-kappa B in cytokine gene regulation
18. Cytokine-induced neutrophil chemoattractant mediates neutrophilic alveolitis in rats: Association with nuclear factor kappa B activation
19. The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers
20. Lymphocyte activation and the family of NF-kappa B transcription factor complexes
21. Oxidative stress and nuclear factor-kappaB activation: A reassessment of the evidence in the light of recent discoveries
22. Interactions between an HMG-1 protein and members of the Rel family
23. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: Elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival
24. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells
25. Transcriptional regulation of endothelial cell adhesion molecules: A dominant role for NF-kappa B
26. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity
27. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction
28. Endothelial cells in physiology and in the pathophysiology of vascular disorders
29. IKAP is a scaffold protein of the IkappaB kinase complex
30. Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B
31. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules
32. IL-13 is transcriptionally expressed in IgG-immune complex-induced lung injury
33. Inhibition of E-selectin gene expression by transforming growth factor beta in endothelial cells involves coactivator integration of Smad and nuclear factor kappaB-mediated signals
34. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB
35. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups
36. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome
37. Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury
38. Mechanisms and consequences of activation of protein kinase B/Akt
39. Multiple organ failure in polytrauma patients
40. Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: Role of tumor necrosis factor
41. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: Role in pulmonary inflammation following lipopolysaccharide
42. Constitutive NF-kappaB levels in human alveolar macrophages from normal volunteers
43. Mechanisms of proliferative and obliterative vascular diseases. Insights from the pulmonary and systemic circulations. NHLBI workshop summary
44. Adult respiratory distress syndrome: Risk with common predispositions
45. The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p 50 homodimers from select kappa B sites
46. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers
47. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome
48. Depletion of alveolar macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections
49. NF-kappaB and the innate immune response
50. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia
51. A Toll-like receptor recognizes bacterial DNA
52. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation
53. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase
54. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome
55. Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha
56. Approaching the asymptote? Evolution and revolution in immunology
57. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB
58. High mobility group protein-1 (HMG-1) is a unique activator of p53
59. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: A prospective, randomized, placebo-controlled study
60. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B
61. Acute immunologic pulmonary alveolitis
62. Unresponsiveness of MyD88-deficient mice to endotoxin
63. Cytokines of the lung
64. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway
65. Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression
66. Diversity and specificity in transcriptional regulation: The benefits of heterotypic dimerization
67. Hemorrhage increases cytokine expression in lung mononuclear cells in mice: Involvement of catecholamines in nuclear factor-kappaB regulation and cytokine expression
68. Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB
69. NF-kappaB activation during IgG immune complex-induced lung injury: Requirements for TNF-alpha and IL-1beta but not complement
70. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13
71. IKK1-deficient mice exhibit abnormal development of skin and skeleton
72. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene
73. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production
74. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide
75. TNF-alpha gene expression in macrophages: Regulation by NF-kappa B is independent of c-Jun or C/EBP beta
76. In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock
77. Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes
78. Pyrrolidine dithiocarbamate prevents I-kappaB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs
79. Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment
80. Multivalent DNA-binding properties of the HMG-1 proteins
81. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1
82. NF-kappa B is activated during acute inflammation in vivo in association with elevated endothelial cell adhesion molecule gene expression and leukocyte recruitment
83. Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity
84. Neutrophil apoptosis in the acute respiratory distress syndrome
85. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex
86. Signal transduction through NF-kappa B
87. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome
88. Innate immunity: The virtues of a nonclonal system of recognition
89. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
90. IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex
91. IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NF-kappaB activation
92. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor
93. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality
94. Systemic blood loss affects NF-κB regulatory mechanisms in the lungs
95. Evolving concepts in the pathogenesis of postinjury multiple organ failure
96. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1
97. NF-kappa B precursor pl00 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors
98. Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase
99. The binding of a Fos/Jun heterodimer can completely disrupt the structure of a nucleosome
100. Cutting edge: Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression
101. Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells
102. Specificity in the innate response: Pathogen recognition by Toll-like receptor combinations
103. Toll-like receptor (TLR)-2 mediates Treponema glycolipid and lipoteichoic acid (LTA)induced NF-kappa B translocation
104. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase
105. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation
106. Neutrophil apoptosis in the lung after hemorrhage or endotoxemia: Apoptosis and migration are independent of interleukin-1beta
107. Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia
108. Mediators and mechanisms of acute lung injury
109. Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients
110. The role of endothelial cells in inflammation
111. NF-kappaB activation by a signaling complex containing TRAF2, TANKand TBK1, a novel IKK-related kinase
112. Identification and characterization of an IkappaB kinase
113. Scientific perspectives on adult respiratory distress syndrome
114. Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase
115. Oxidants in mitochondria: From physiology to diseases
116. A family of human receptors structurally related to Drosophila Toll
117. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex
118. Early predictors of postinjury multiple organ failure
119. Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding
120. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells
121. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids
122. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2
123. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome
124. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
125. Regulation of immune responses by NF-kappa B/Rel transcription factor
126. Regulatory effects of interleukin-6 in immunoglobulin G immune-complex-induced lung injury
127. Regulatory effects of endogenous interleukin-1 receptor antagonist protein in immunoglobulin G immune complex-induced lung injury
128. Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury
129. Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury
130. Regulation of chemokine expression by IL-10 in lung inflammation
131. Hemorrhage induces rapid in vivo activation of CREB and NF-kappaB in murine intraparenchymal lung mononuclear cells
132. Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: Roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein
133. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases
134. Structure regulation and function of NF-kappa B
135. Site-specific tyrosine phosphorylation of IkappaBalpha negatively regulates its inducible phosphorylation and degradation
136. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B
137. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function
138. Functional and physical associations between NF-kappa B and C/EBP family members: A Rel domain-bZIP interaction
139. Kupffer cell activation by lipopolysaccharide in rats: Role for lipopolysaccharide binding protein and toll-like receptor 4
140. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study
141. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components
142. TLR6: A novel member of an expanding toll-like receptor family
143. Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10
144. Distinct functional properties of IkappaB alpha and IkappaB beta
145. Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1 beta gene
146. Scissors-grip model for DNA recognition by a family of leucine zipper proteins
147. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase- 8 activation
148. HMG-1 as a late mediator of endotoxin lethality in mice
149. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms
150. Lung inflammation and fibrosis
151. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase
152. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family
153. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity
154. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK
155. Mechanisms of neutrophil mediated injury
156. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation
157. Cutting edge: Recognition of Grampositive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2
158. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation
159. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase- beta
160. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation
161. Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes